Canadian imaging: strong & steady growth to 2010 expected
This article was originally published in Clinica
Canada's imaging market for new equipment is currently estimated to be US$1.6bn. Demand is expected to grow at a rate of 5-10% until 2010, according to a US Commercial Service report, which records a 7% growth in demand for imaging technologies in Canada over the past five years.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.